AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2018
May 21, 2018
34129_dirs_2018-05-21_86b1a830-1330-4b96-8112-de0026a8d2e4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-05-17
Reporting Person: Ferrante Karen Jean (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-17 | Stock Option (right to buy) | $21.34 | A | 10000 | Acquired | 2028-05-17 | Common Stock (10000.0) | Direct |
Footnotes
F1: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
More from MACROGENICS INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18